Today’s Headlines: Updates on the Zika Virus and The EpiPen Problem

Mosquitos carrying the Zika virus can pass it onto their offspring. Researchers have found that it’s possible for female mosquitoes to both transmit and inherit the Zika virus although occurrences are rare. “The Zika virus can be transmitted by a female mosquito to her eggs, eventually infecting her adult daughters, researchers reported on Monday. But mother-daughter transmission happens so rarely among mosquitoes that it is probably not an important factor in the global Zika epidemic, according to the lead author of the study …In the case of Zika, only one daughter Aedes aegypti mosquito out of 300 inherits the virus from an infected mother, Dr. Tesh’s team estimated.” While this may not create a larger threat for the virus, it does mean that the Zika virus has a higher chance of surviving the winter. (NYT)

The Zika virus may cause hearing loss. A new study was released that said the virus could affect babies’ hearing. “Scientists report that out of 70 kids with Zika-related microcephaly, four had hearing loss that was caused by damage to the inner ear or damage to the nerve that connects the ear to the brain. The hearing loss couldn’t be attributed to any other cause.” Hearing loss joins microcephaly in the list of growing risks associated with the Zika virus.  (Time)

Mylan, the company that manufactures and sells EpiPen, announced they will be making a generic version of the drug. The company will sell the generic epinephrine medicine at a 50 percent discount than the branded drug, that skyrocketed to $600 for a pack of two recently. “The company said Monday that its U.S. subsidiary will put out a generic version of the EpiPen that will have a list price of $300 for a two-pack — about half the current price. It will be available in both 0.15 mg and 0.30 mg strengths.” Meanwhile, two other drug companies are looking for government approval to sell their epinephrine products to rival EpiPen. (NBC)